Profile
Dr Richard Yeo is a Senior Consultant specialising in women’s cancer in the Division of Radiation Oncology, National Cancer Centre Singapore. He is also a visiting consultant at KK Women’s and Children’s Hospital and Changi General Hospital.
Dr Yeo’s research interests include brachytherapy especially in breast and gynaecological cancers. He is also site Principal Investigator at NCCS for NRG Oncology, a large cooperative group of multinational cancer centres doing research in cancer treatment.
Professional Appointments and Committee Memberships
- Site Principal Investigator, NCCS RTOG/NRG trials
View More +
Publications
- Associations of lifestyle and diet with the risk of nasopharyngeal carcinoma in Singapore: a case-control study
Yong SK, Ha TC, Yeo MC, Gaborieau V, McKay JD, Wee J
Chin J Cancer, 2017; 36(1)
- Validation of a nomogram in the prediction of local recurrence risks after conserving surgery for Asian women with ductal carcinoma in situ of the breast
F Wang, H Li, PH Tan, ET Chua, RM Yeo, FLWT Lim, SW Kim, DYH Tan, FY Wong
Clin Oncol 2014 Nov; 26(11): 684-91
- The effect of test kit provision, and individual and family education on the uptake rates of fecal occult blood test in an Asian population: a randomized controlled trial
Ha TC, Yong SK, Yeoh KW, Kamberakis K, Yeo RM, Koh GC
Cancer Causes Control, 2014 Aug 5
- Why are East Asians more susceptible to several infection-associated cancers (carcinomas of the nasopharynx, stomach, liver, adenocarcinoma of the lung, nasal NK.T-cell lymphomas)?
Wee K, Nei WL, Yeoh KW, Kamberakis K, Yeo RM, Koh GC
Med Hypotheses, 2012 Dec; 79(6) 833-42
- Cancer and radiation therapy: current advances and future directions.
Baskar R, Lee KA, Yeo R, Yeoh KW
Int J Med Sci. 2012;9(3):193-9. Epub 2012 Feb 27
- Survival Outcome of women with synchronous cancers of endometrium and ovary: a 10 year retrospective cohort study
YK Lim, R Padma, L Foo, YN Chia, P Yam, J Chia, SP Yap, R Yeo
Journal of Gynaecologic Oncology, Dec 11, 22(4): 239 - 243
- Tailoring adjuvant radiotherapy for Stage IB – IIA node negative cervical cancer after radical hysterectomy and pelvic lymph node dissection using the GOG score
Richard MC Yeo, YN Chia, Rama PD Namduri, SP Yap, YL Soong, PKL Yam, TYK Lim, HS Khoo-Tan
Gynecologic Oncology, Nov 11, 123(2): 225-229
- Stage 1C Grade 3 Endometrial Cancer: The KK Hospital Gynaecological Oncology Group Experience.
Siow TR, Yeo MC, Khoo-Tan HS, Yap SP, Soong YL, Chua EJ, Soh LT, Lim YK, Chia YN, Yam KL
International Journal of Gynecological Cancer, Dec 10, 20(9): 1557-62
- Survival and Disease Relapse in Surgical Stage I Endometrioid Adenocarcinoma of the Uterus After Adjuvant Vaginal Vault Brachytherapy
VJ Kumar, YN Chia, YK Lim, HS KhooTan, R Yeo, PKL Yam
International Journal of Gynecological Cancer, May 10, 20(4): 564-69
- Concurrent Chemoradiotherapy Incorporating High Dose Rate Brachytherapy for Locally Advanced Cervical Carcinoma Survival: Outcomes, Patterns of Failure, and Prognostic Factors
J Teh, SP Yap, I Tham, VK Sethi, EJ Chua, R Yeo, TH Ho, EH Tay, YN Chia, LT Soh and HS Khoo-Tan
International Journal of Gynecological Cancer, Apr 10, 20(3): 428-33
View More +
